Market Closed -
Nyse
04:00:01 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
96.06
USD
|
+0.90%
|
|
+0.07%
|
+13.94%
|
Fiscal Period: September |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
4,663
|
4,289
|
5,413
|
5,142
|
4,185
|
4,812
|
-
|
-
|
Enterprise Value (EV)
1 |
6,098
|
5,688
|
7,173
|
5,766
|
5,120
|
5,811
|
5,854
|
5,947
|
P/E ratio
|
9.6
x
|
-8.45
x
|
24.8
x
|
5.79
x
|
24.7
x
|
29.2
x
|
21.2
x
|
15.9
x
|
Yield
|
1.36%
|
1.55%
|
1.29%
|
1.34%
|
-
|
1.68%
|
1.82%
|
1.95%
|
Capitalization / Revenue
|
1.87
x
|
1.84
x
|
2.56
x
|
2.14
x
|
1.91
x
|
2.2
x
|
2.09
x
|
1.97
x
|
EV / Revenue
|
2.44
x
|
2.45
x
|
3.4
x
|
2.4
x
|
2.34
x
|
2.65
x
|
2.54
x
|
2.43
x
|
EV / EBITDA
|
11.5
x
|
10.8
x
|
14.5
x
|
9.77
x
|
11.2
x
|
12.3
x
|
10.5
x
|
9.8
x
|
EV / FCF
|
82.4
x
|
32.5
x
|
19.9
x
|
72.1
x
|
41.3
x
|
19.3
x
|
22.5
x
|
20.8
x
|
FCF Yield
|
1.21%
|
3.08%
|
5.03%
|
1.39%
|
2.42%
|
5.18%
|
4.45%
|
4.8%
|
Price to Book
|
1.36
x
|
1.42
x
|
1.98
x
|
1.65
x
|
-
|
1.65
x
|
1.65
x
|
1.6
x
|
Nbr of stocks (in thousands)
|
60,522
|
60,470
|
60,733
|
54,139
|
51,241
|
50,095
|
-
|
-
|
Reference price
2 |
77.05
|
70.92
|
89.12
|
94.97
|
81.68
|
96.06
|
96.06
|
96.06
|
Announcement Date
|
11/18/19
|
11/10/20
|
11/9/21
|
11/7/22
|
11/8/23
|
-
|
-
|
-
|
Fiscal Period: September |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2,500
|
2,326
|
2,111
|
2,400
|
2,191
|
2,191
|
2,304
|
2,448
|
EBITDA
1 |
532
|
528
|
495
|
590
|
459
|
473.5
|
557.8
|
607.1
|
EBIT
1 |
283
|
277
|
251
|
349
|
224
|
233.2
|
307.8
|
358.7
|
Operating Margin
|
11.32%
|
11.91%
|
11.89%
|
14.54%
|
10.22%
|
10.64%
|
13.36%
|
14.65%
|
Earnings before Tax (EBT)
1 |
70
|
-503
|
135
|
206
|
160
|
148.2
|
221.5
|
246
|
Net income
1 |
505
|
-508
|
220
|
927
|
178
|
154.4
|
200.4
|
275
|
Net margin
|
20.2%
|
-21.84%
|
10.42%
|
38.62%
|
8.12%
|
7.05%
|
8.7%
|
11.23%
|
EPS
2 |
8.030
|
-8.390
|
3.590
|
16.41
|
3.310
|
3.295
|
4.524
|
6.031
|
Free Cash Flow
1 |
74
|
175
|
361
|
80
|
124
|
300.9
|
260.7
|
285.5
|
FCF margin
|
2.96%
|
7.52%
|
17.1%
|
3.33%
|
5.66%
|
13.74%
|
11.32%
|
11.66%
|
FCF Conversion (EBITDA)
|
13.91%
|
33.14%
|
72.93%
|
13.56%
|
27.02%
|
63.56%
|
46.73%
|
47.03%
|
FCF Conversion (Net income)
|
14.65%
|
-
|
164.09%
|
8.63%
|
69.66%
|
194.9%
|
130.12%
|
103.81%
|
Dividend per Share
2 |
1.050
|
1.100
|
1.150
|
1.270
|
-
|
1.617
|
1.747
|
1.878
|
Announcement Date
|
11/18/19
|
11/10/20
|
11/9/21
|
11/7/22
|
11/8/23
|
-
|
-
|
-
|
Fiscal Period: September |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
591
|
512
|
604
|
644
|
631
|
525
|
603
|
546
|
518
|
473
|
574.7
|
584
|
562.4
|
504.9
|
606
|
EBITDA
1 |
149
|
106
|
163
|
174
|
147
|
108
|
145
|
133
|
74
|
70
|
121.6
|
141.7
|
140.5
|
111.6
|
150.5
|
EBIT
1 |
85
|
46
|
101
|
114
|
87
|
50
|
87
|
73
|
14
|
16
|
62.54
|
81.63
|
79.2
|
49.85
|
88.93
|
Operating Margin
|
14.38%
|
8.98%
|
16.72%
|
17.7%
|
13.79%
|
9.52%
|
14.43%
|
13.37%
|
2.7%
|
3.38%
|
10.88%
|
13.98%
|
14.08%
|
9.87%
|
14.68%
|
Earnings before Tax (EBT)
1 |
31
|
37
|
58
|
52
|
61
|
50
|
91
|
57
|
-38
|
4
|
45.5
|
55.5
|
54
|
37
|
58
|
Net income
1 |
43
|
48
|
786
|
36
|
57
|
40
|
91
|
50
|
-4
|
26
|
34.22
|
55.04
|
50.34
|
32.51
|
59.24
|
Net margin
|
7.28%
|
9.38%
|
130.13%
|
5.59%
|
9.03%
|
7.62%
|
15.09%
|
9.16%
|
-0.77%
|
5.5%
|
5.95%
|
9.43%
|
8.95%
|
6.44%
|
9.78%
|
EPS
2 |
0.7200
|
0.8300
|
13.69
|
0.6500
|
1.040
|
0.7300
|
1.670
|
0.9400
|
-0.0700
|
0.5100
|
0.8881
|
1.403
|
1.236
|
0.7318
|
1.528
|
Dividend per Share
2 |
0.3000
|
0.3000
|
0.3000
|
0.3350
|
0.3350
|
0.3350
|
0.3350
|
0.3850
|
-
|
-
|
0.3974
|
0.4228
|
0.4228
|
0.4384
|
0.4384
|
Announcement Date
|
11/9/21
|
2/1/22
|
4/26/22
|
7/26/22
|
11/7/22
|
1/31/23
|
5/2/23
|
7/25/23
|
11/8/23
|
1/30/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: September |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
1,435
|
1,399
|
1,760
|
624
|
935
|
999
|
1,042
|
1,135
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.697
x
|
2.65
x
|
3.556
x
|
1.058
x
|
2.037
x
|
2.11
x
|
1.867
x
|
1.869
x
|
Free Cash Flow
1 |
74
|
175
|
361
|
80
|
124
|
301
|
261
|
286
|
ROE (net income / shareholders' equity)
|
4.5%
|
5.18%
|
7.6%
|
10.8%
|
27.1%
|
7.86%
|
9.82%
|
11.1%
|
ROA (Net income/ Total Assets)
|
2.02%
|
2.42%
|
3.26%
|
5.02%
|
3.59%
|
3.74%
|
4.31%
|
4.83%
|
Assets
1 |
24,944
|
-20,986
|
6,745
|
18,461
|
4,961
|
4,128
|
4,653
|
5,695
|
Book Value Per Share
2 |
56.70
|
49.80
|
44.90
|
57.50
|
-
|
58.30
|
58.40
|
59.90
|
Cash Flow per Share
2 |
3.620
|
5.130
|
7.640
|
3.450
|
5.440
|
7.710
|
9.410
|
11.30
|
Capex
1 |
154
|
138
|
105
|
113
|
170
|
153
|
145
|
168
|
Capex / Sales
|
6.16%
|
5.93%
|
4.97%
|
4.71%
|
7.76%
|
6.97%
|
6.29%
|
6.85%
|
Announcement Date
|
11/18/19
|
11/10/20
|
11/9/21
|
11/7/22
|
11/8/23
|
-
|
-
|
-
|
Last Close Price
96.06
USD Average target price
106.8
USD Spread / Average Target +11.20% Consensus |
1st Jan change
|
Capi.
|
---|
| +13.94% | 4.81B | | -0.19% | 74.89B | | +0.09% | 46.52B | | -4.19% | 30.82B | | +9.85% | 18.19B | | -10.05% | 11.54B | | +6.39% | 11.24B | | -8.09% | 9.73B | | +2.79% | 9.4B | | +6.35% | 9.37B |
Diversified Chemicals
|